Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01331564 · ClinicalTrials.gov registry record · Phase 3
eMOMS of Rochester
A Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,641
- Enrollment target
- 1
- Study location
NCT01331564: Completed Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention, sponsored by University of Rochester.
NCT01331564 is a Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention that has completed, run by University of Rochester. The registered enrollment target is 1,641 participants, above the 259-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (534% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01331564, a Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,641 participants
- Enrollment target
- 1
- Study location
Study Summary
The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.
Primary Outcome
Gestational weight gain is the result of the last predelivery weight minus the prepregnancy weight (or early pregnancy weight).
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL electronic intervention during pregnancy and postpartum
- BEHAVIORAL electronic intervention during pregnancy
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,641 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-12 |
| Phase | Phase 3 |
What the finished NCT01331564 record still lists
NCT01331564 is an interventional study that assigns participants to a tested intervention. Its 1,641 participants enrollment target places it among the larger protocols in the corpus, above the 259-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (534% higher).
The record links to 2 conditions, with Gestational Weight Gain appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT01331564 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01331564 about?
NCT01331564 is a clinical study titled "eMOMS of Rochester". The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.
What is the current status of trial NCT01331564?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,641 participants. The study started on 2011-05. Estimated completion is 2014-12.
What conditions does trial NCT01331564 study?
This clinical trial studies the following conditions: Gestational Weight Gain, Postpartum Weight Retention.
What interventions are being tested in trial NCT01331564?
The interventions under investigation include: Control (BEHAVIORAL), electronic intervention during pregnancy and postpartum (BEHAVIORAL), electronic intervention during pregnancy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01331564?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01331564 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Weight Gain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Healthy Mom Zone Gestational Weight Gain Management Intervention 2.0
RECRUITING · NA
-
Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy
RECRUITING · NA
-
Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC
COMPLETED · NA
-
Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia